FGF4
Fibroblast growth factor 4 is a protein that in humans is encoded by the FGF4 gene.[1][2]
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene was identified by its oncogenic transforming activity. This gene and FGF3, another oncogenic growth factor, are located closely on chromosome 11. Co-amplification of both genes was found in various kinds of human tumors. Studies on the mouse homolog suggested a function in bone morphogenesis and limb development through the sonic hedgehog (SHH) signaling pathway.[2]
Function
During embryonic development, the 21-kD protein FGF4 functions as a signaling molecule that is involved in many important processes.[3][4] Studies using Fgf4 gene knockout mice showed developmental defects in embryos both in vivo and in vitro, revealing that FGF4 facilitates the survival and growth of the inner cell mass during the postimplantation phase of development by acting as an autocrine or paracrine ligand.[3] FGFs produced in the apical ectodermal ridge (AER) are critical for the proper forelimb and hindlimb outgrowth.[5] FGF signaling in the AER is involved in regulating limb digit number and cell death in the interdigital mesenchyme.[6] When FGF signaling dynamics and regulatory processes are altered, postaxial polydactyly and cutaneous syndactyly, two phenotypic abnormalities collectively known as polysyndactyly, can occur in the limbs. Polysyndactyly is observed when an excess of Fgf4 is expressed in limb buds of wild-type mice. In mutant limb buds that do not express Fgf8, the expression of Fgf4 still results in polysyndactyly, but Fgf4 is also able to rescue all skeletal defects that arise from the lack of Fgf8. Therefore, the Fgf4 gene compensates for the loss of the Fgf8 gene, revealing that FGF4 and FGF8 perform similar functions in limb skeleton patterning and limb development.[6] Studies of zebrafish Fgf4 knockdown embryos demonstrated that when Fgf4 signaling is inhibited, randomized left-right patterning of the liver, pancreas, and heart takes place, showing that Fgf4 is a crucial gene involved in developing left-right patterning of visceral organs. Furthermore, unlike the role of FGF4 in limb development, FGF4 and FGF8 have distinct roles and function independently in the process of visceral organ left-right patterning.[7]
References
- ↑ Galland F, Stefanova M, Lafage M, Birnbaum D (Jul 1992). "Localization of the 5' end of the MCF2 oncogene to human chromosome 15q15----q23". Cytogenet Cell Genet 60 (2): 114–6. doi:10.1159/000133316. PMID 1611909.
- ↑ 2.0 2.1 "Entrez Gene: FGF4 fibroblast growth factor 4 (heparin secretory transforming protein 1, Kaposi sarcoma oncogene)".
- ↑ 3.0 3.1 Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M (1995). "Requirement of FGF-4 for postimplantation mouse development". Science 267 (5195): 246–9. doi:10.1126/science.7809630. PMID 7809630.
- ↑ Yuan H, Corbi N, Basilico C, Dailey L (1995). "Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3". Genes Dev. 9 (21): 2635–45. doi:10.1101/gad.9.21.2635. PMID 7590241.
- ↑ Boulet AM, Moon AM, Arenkiel BR, Capecchi MR (2004). "The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth". Dev. Biol. 273 (2): 361–72. doi:10.1016/j.ydbio.2004.06.012. PMID 15328019.
- ↑ 6.0 6.1 Lu P, Minowada G, Martin GR (2006). "Increasing Fgf4 expression in the mouse limb bud causes polysyndactyly and rescues the skeletal defects that result from loss of Fgf8 function". Development 133 (1): 33–42. doi:10.1242/dev.02172. PMID 16308330.
- ↑ Yamauchi H, Miyakawa N, Miyake A, Itoh N (2009). "Fgf4 is required for left-right patterning of visceral organs in zebrafish". Dev. Biol. 332 (1): 177–85. doi:10.1016/j.ydbio.2009.05.568. PMID 19481538.
Further reading
- Powers CJ, McLeskey SW, Wellstein A (2000). "Fibroblast growth factors, their receptors and signaling.". Endocr. Relat. Cancer 7 (3): 165–97. doi:10.1677/erc.0.0070165. PMID 11021964.
- Taira M, Yoshida T, Miyagawa K et al. (1987). "cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity". Proc. Natl. Acad. Sci. U.S.A. 84 (9): 2980–4. doi:10.1073/pnas.84.9.2980. PMC 304784. PMID 2953031.
- Delli Bovi P, Curatola AM, Kern FG et al. (1987). "An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family". Cell 50 (5): 729–37. doi:10.1016/0092-8674(87)90331-X. PMID 2957062.
- Yoshida T, Miyagawa K, Odagiri H et al. (1987). "Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein". Proc. Natl. Acad. Sci. U.S.A. 84 (20): 7305–9. doi:10.1073/pnas.84.20.7305. PMC 299281. PMID 2959959.
- Wada A, Sakamoto H, Katoh O et al. (1989). "Two homologous oncogenes, HST1 and INT2, are closely located in human genome". Biochem. Biophys. Res. Commun. 157 (2): 828–35. doi:10.1016/S0006-291X(88)80324-3. PMID 2974287.
- Huebner K, Ferrari AC, Delli Bovi P et al. (1989). "The FGF-related oncogene, K-FGF, maps to human chromosome region 11q13, possibly near int-2". Oncogene Res. 3 (3): 263–70. PMID 3060803.
- Adelaide J, Mattei MG, Marics I et al. (1988). "Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma". Oncogene 2 (4): 413–6. PMID 3283658.
- Ornitz DM, Xu J, Colvin JS et al. (1996). "Receptor specificity of the fibroblast growth factor family". J. Biol. Chem. 271 (25): 15292–7. doi:10.1074/jbc.271.25.15292. PMID 8663044.
- Tanaka S et al. (1998). "Promotion of trophoblast stem cell proliferation by FGF-4". Science 282: 2072–2075. doi:10.1126/science.282.5396.2072.
- Helland R, Berglund GI, Otlewski J et al. (1999). "High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes". Acta Crystallogr. D Biol. Crystallogr. 55 (Pt 1): 139–48. doi:10.1107/S090744499801052X. PMID 10089404.
- Bellosta P, Iwahori A, Plotnikov AN et al. (2001). "Identification of Receptor and Heparin Binding Sites in Fibroblast Growth Factor 4 by Structure-Based Mutagenesis". Mol. Cell. Biol. 21 (17): 5946–57. doi:10.1128/MCB.21.17.5946-5957.2001. PMC 87313. PMID 11486033.
- Britto JA, Evans RD, Hayward RD, Jones BM (2002). "From genotype to phenotype: the differential expression of FGF, FGFR, and TGFbeta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes". Plast. Reconstr. Surg. 108 (7): 2026–39; discussion 2040–6. doi:10.1097/00006534-200112000-00030. PMID 11743396.
- Yamamoto H, Ochiya T, Tamamushi S et al. (2002). "HST-1/FGF-4 gene activation induces spermatogenesis and prevents adriamycin-induced testicular toxicity". Oncogene 21 (6): 899–908. doi:10.1038/sj.onc.1205135. PMID 11840335.
- Sieuwerts AM, Martens JW, Dorssers LC et al. (2003). "Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts". Thromb. Haemost. 87 (4): 674–83. PMID 12008951.
- Koh KR, Ohta K, Nakamae H et al. (2002). "Differential effects of fibroblast growth factor-4, epidermal growth factor and transforming growth factor-beta1 on functional development of stromal layers in acute myeloid leukemia". Leuk. Res. 26 (10): 933–8. doi:10.1016/S0145-2126(02)00033-4. PMID 12163055.
- Lopez-Sanchez C, Climent V, Schoenwolf GC et al. (2003). "Induction of cardiogenesis by Hensen's node and fibroblast growth factors". Cell Tissue Res. 309 (2): 237–49. doi:10.1007/s00441-002-0567-2. PMID 12172783.
- Wang P, Branch DR, Bali M et al. (2003). "The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells". Biochem. J. 375 (Pt 1): 199–205. doi:10.1042/BJ20030579. PMC 1223663. PMID 12841847.
- Reményi A, Lins K, Nissen LJ et al. (2003). "Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers". Genes Dev. 17 (16): 2048–59. doi:10.1101/gad.269303. PMC 196258. PMID 12923055.
- Hirai K, Sasaki H, Yamamoto H et al. (2004). "HST-1/FGF-4 protects male germ cells from apoptosis under heat-stress condition". Exp. Cell Res. 294 (1): 77–85. doi:10.1016/j.yexcr.2003.11.012. PMID 14980503.
- Grigor’eva EV et al. (2009). "FGF4 independent derivation of trophoblast stem cells from the common vole". PLoS ONE 4 (9): 1–10. doi:10.1371/journal.pone.0007161.
- Boulet AM and Capecchi MR (2012). "Signaling by FGF4 and FGF8 is required for axial elongation of the mouse embryo". Developmental Biology 371 (2): 235–245. doi:10.1016/j.ydbio.2012.08.017.
PDB gallery |
---|
| | 1ijt: Crystal Structure of Fibroblast Growth Factor 4 (FGF4) |
|
|
|
Intercellular signaling peptides and proteins / ligands |
---|
| Growth factors | |
---|
| Ephrin | |
---|
| Other | |
---|
| see also extracellular ligand disorders
Index of signal transduction |
---|
| Description |
- Intercellular
- neuropeptides
- growth factors
- cytokines
- hormones
- Cell surface receptors
- ligand-gated
- enzyme-linked
- G protein-coupled
- immunoglobulin superfamily
- integrins
- neuropeptide
- growth factor
- cytokine
- Intracellular
- adaptor proteins
- GTP-binding
- MAP kinase
- Calcium signaling
- Lipid signaling
- Pathways
- hedgehog
- Wnt
- TGF beta
- MAPK ERK
- notch
- JAK-STAT
- apoptosis
- hippo
- TLR
|
---|
|
|